Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 1, 2015, Pages 81-86

  Solmaz, Ulas ^a   Mat, Emre ^a   Dereli, Murat ^b   Turan, Volkan ^a   Gungorduk, Kemal ^a   Hasdemir, Pinar ^c   Tosun, Gokhan ^a   Dogan, Askin ^a   Ozdemir, Aykut ^a   Adiyeke, Mehmet ^a   Sanci, Muzaffer ^a  

^a TEPECIK EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b DENIZLI STATE HOSPITAL   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

cervical stromal invasion; endometrial cancer; lymph node metastasis; lymphadenectomy; lymphovascular space invasion

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CERVICAL STROMAL INVASION; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TUMOR INVASION; AGED; AORTA; BLOOD VESSEL; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; LYMPH VESSEL; MIDDLE AGED; PATHOLOGY; PELVIS; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; UTERINE CERVIX;

AGED; AORTA; BLOOD VESSELS; CARCINOMA, ENDOMETRIOID; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; PELVIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84923220033     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12321     Document Type: Article

References (22)

1. Nicolaije KA, Ezendam NP, Vos MC, et al,. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based profiles registry. Gynecol Oncol 2013; 129: 324-331.
2. Soliman PT, Frumovitz M, Spannuth W, et al,. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol 2010; 119: 291-294.
3. Carter J,. A contemporary review of uterine cancer management. Aust N Z J Obstet Gynaecol 2013; 53: 517-524.
4. Mariani A, Webb MJ, Keeney GL, et al,. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J ObstetGynecol 2000; 182: 1506-1519.
5. Cragun JM, Havrilesky LJ, Calingaert B, et al,. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23: 3668-3675.
6. Creutzberg CL, van Putten WL, Koper PC, et al,. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicenter randomized trial. PORTEC study group Postoperative radiation Therapy in Endometrial Cancer. Lancet 2000; 355: 1404-1411.
7. Keyes HM, Roberts JA, Brunetto VL, et al,. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 94: 241-242.
8. Gadducci A, Cavazzana A, Cosio S, et al,. Lymph vascular space involvement and outer onethird myometrial invasion are strong predictors of distant hematogenous failures in patients with stage I-II endometrioid-type endometrial cancer. Anticancer Res 2009; 29: 1715-1720.
9. Guntupalli SR, Zighelboim I, Kizer NT, et al,. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol 2012; 124: 31-35.
10. Hahn HS, Lee IH, Kim TJ, et al,. Lymphovascular space invasion is highly associated with lymph node metastases and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol 2013; 53: 293-297.
11. Rasool N, Fader AN, Seamon L, et al,. Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol 2010; 116: 10-14.
12. Boren T, Lea J, Kehoe S, et al,. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement. Gynecol Oncol 2012; 127: 43-46.
13. Ahmad K, Kim YH, Deppe G, et al,. Radiation therapy in stage II carcinoma of theendometrium. Cancer 1989; 63: 854-858.
14. Morrow CP, Bundy BN, Kurman RJ, et al,. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
15. Eltabbakh GH, Moore AD,. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999; 74: 80-85.
16. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ,. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 1999; 181: 31-34.
17. Nomura H, Aoki D, Suzuki N, et al,. Analysis of clinicopathologic factors predicting paraaortic lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 2006; 16: 799-804.
18. Shah C, Johnson E, Everett E, et al,. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer Gynecol Oncol 2005; 99: 564-570.
19. Kitchener H, Swart AM, Qian Q, et al,. Efficacy of systemic pelvic lymphadenectomy in early stage endometrial cancer (MRC ASTEC trial): a randomized controlled trial. Lancet 2009; 373: 125-136.
20. Kilgore LC, Partridge EE, Alvarez RD, et al,. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56: 29-33.
21. Creasman WT, Morrow CP, Bundy BN, et al,. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-2041.
22. Mariani A, Dowdy SC, Cliby WA, et al,. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-18.